Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice

Brain tumor incidence is on the rise, and glioblastoma comprises the majority of primary tumors. Despite maximal safe resection and adjuvant chemoradiation, median survival for high-grade glioma remains poor. For this reason, it is important to develop and incorporate new treatment strategies. Oncol...

Descripción completa

Detalles Bibliográficos
Autores principales: Soldozy, Sauson, Eichberg, Daniel G., Morell, Alexis A., Luther, Evan, Lu, Victor M., Higgins, Dominique M. O., Patel, Nitesh V., Shah, Ashish H., Hanft, Simon J., Komotar, Ricardo J., Ivan, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386040/
https://www.ncbi.nlm.nih.gov/pubmed/37513708
http://dx.doi.org/10.3390/pathogens12070861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386040/
https://www.ncbi.nlm.nih.gov/pubmed/37513708
http://dx.doi.org/10.3390/pathogens12070861

Ejemplares similares